| 187 A LIQUID BIOPSY EXOSOMAL MICRORNA PANEL FOR PREDICTING RECURRENCE FOLLOWING SURGERY IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA S Nishiwada, Y Cui, M Sho, E Jun, T Akahori, K Nakamura, F Sonohara, ... Gastroenterology 160 (6), S-46, 2021 | | 2021 |
| 307: FEASIBILITY OF AUTOMATIC MACHINE LEARNING (AUTOML) TO PREDICT 90-DAY MORTALITY AFTER GASTRECTOMY FOR CANCER G SenthilKumar, N Koerber, J Merrill, CN Clarke, UN Maduekwe, S Tsai, ... Gastroenterology 162 (7), S-1319, 2022 | 1 | 2022 |
| 391–Comprehensive Genomic Profiling of Pancreatic Cancer Tumor Specimens: is More Better? A Krepline, M Aldakkak, K Christians, B George, PS Ritch, W Hall, ... Gastroenterology 156 (6), S-1396, 2019 | | 2019 |
| 6 Pancreatic Cancer Initial Staging Exam D Kim, S Tsai, PP Tolat Radiology Structured Reporting Handbook: Disease-Specific Templates and …, 2021 | | 2021 |
| 612 IMPACT OF HOSPITAL FLAGSHIP SYSTEM AFFILIATION ON SURGICAL OUTCOMES FOLLOWING COMPLEX CANCER SURGERY MM Munir, S Woldesenbet, MMM Khan, S Tsai, TM Pawlik Gastroenterology 166 (5), S-1803, 2024 | | 2024 |
| 711 Poor Glycemic Control is Associated With Failure to Complete Neoadjuvant Therapy and Surgery in Patients With Localized Pancreatic Cancer EP Rajamanickam, M Aldakkak, K Christians, B George, PS Ritch, ... Gastroenterology 150 (4), S1188, 2016 | | 2016 |
| 899 MAGNITUDE OF CA19-9 DECLINE IN RESPONSE TO NEOADJUVANT CHEMORADIATION IS ASSOCIATED WITH OVERALL SURVIVAL IN PATIENTS WITH PANCREATIC CANCER S Thalji, W Hall, M Aldakkak, K Christians, CN Clarke, B George, ... Gastroenterology 160 (6), S-902, 2021 | 1 | 2021 |
| 962-Conditional Survival Following Neoadjuvant Therapy and Surgery for Patients with Localized Pancreatic Cancer from the National Cancer Database C Barnes, Y Cho, M Aldakkak, C Clarke, K Christians, KS Dua, G Lomberk, ... Gastroenterology 6 (154), S-1298, 2018 | | 2018 |
| 963-Total Pancreatectomy after Neoadjuvant Therapy for Operable Pancreatic Cancer: A Contemporary Analysis of the National Cancer Database A Krepline, C Barnes, M Aldakkak, C Clarke, K Christians, B George, ... Gastroenterology 154 (6), S-1298-S-1299, 2018 | | 2018 |
| A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer H Nasief, C Zheng, D Schott, W Hall, S Tsai, B Erickson, X Allen Li NPJ precision oncology 3 (1), 25, 2019 | 134 | 2019 |
| A Multi-biomarker Panel Including Delta Radiomics to Predict Distant Metastasis after Chemoradiation Therapy of Pancreatic Adenocarcinoma H Nasief, WA Hall, C Zheng, S Tsai, BA Erickson, A Li International Journal of Radiation Oncology, Biology, Physics 108 (3), S83, 2020 | | 2020 |
| A non-invasive miRNA signature for the identification of pancreatic ductal adenocarcinoma (PDAC) patients with poor molecular subtypes and worse prognosis R Kandimalla, T Shimura, S Mallik, S Tsai, DB Evans, H Baba, Y Kodera, ... Cancer Research 79 (13_Supplement), 762-762, 2019 | | 2019 |
| A novel reconstruction technique during pancreaticoduodenectomy after Roux-en-Y gastric bypass: how I do it G Younan, S Tsai, DB Evans, KK Christians Journal of Gastrointestinal Surgery 21, 1186-1191, 2017 | 3 | 2017 |
| A phase I study of CPI-613 (devimistat) in combination with chemoradiation in patients with pancreatic adenocarcinoma. M Kamgar, HY Khan, A Aboukameel, S Bannoura, BY Chung, A Szabo, ... Journal of Clinical Oncology 41 (4_suppl), TPS760-TPS760, 2023 | | 2023 |
| A phase II clinical trial of molecular profiled neoadjuvant therapy for localized pancreatic ductal adenocarcinoma S Tsai, KK Christians, B George, PS Ritch, K Dua, A Khan, AC Mackinnon, ... Annals of surgery 268 (4), 610-619, 2018 | 67 | 2018 |
| A pilot study identifying cancer-associated macrophage-like cells in the blood of cancer patients. D Adams, SS Martin, M Charpentier, S Chumsri, RC Bergan, IM Ogden, ... Journal of Clinical Oncology 32 (15_suppl), e22014-e22014, 2014 | | 2014 |
| A randomized, phase II clinical trial of preoperative stereotactic body radiation therapy versus conventionally fractionated chemoradiation for resectable, borderline … WA Hall, S Tsai, A Banerjee, B George, PS Ritch, JP Thomas, E Paulson, ... Journal of Clinical Oncology 37 (15_suppl), TPS4167-TPS4167, 2019 | | 2019 |
| A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or … A Saif, E Verbus, B Erickson, M Kamgar, S Tsai, D Evans, JM Hernandez, ... Annals of surgical oncology 30 (2), 688-690, 2023 | | 2023 |
| A serum-induced transcriptome and serum cytokine signature analyzed from pre-treatment serum obtained at diagnosis correlates with the development of early pancreatic ductal … S Tsai, L McOlash, S Jia, J Zhang, P Simpson, ML Kaldunski, M Aldakkak, ... Cancer epidemiology, biomarkers & prevention: a publication of the American …, 2019 | | 2019 |
| A serum-induced transcriptome and serum cytokine signature obtained at diagnosis correlates with the development of early pancreatic ductal adenocarcinoma metastasis S Tsai, L McOlash, S Jia, J Zhang, P Simpson, ML Kaldunski, M Aldakkak, ... Cancer Epidemiology, Biomarkers & Prevention 28 (4), 680-689, 2019 | 3 | 2019 |
